GO:0050847 progesterone receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050847 describes the nuclear receptor-mediated signaling pathway initiated by progesterone binding to an intracellular progesterone receptor (PGR), leading to regulation of downstream cellular processes such as transcription.
• Progesterone receptor signaling operates through both classical genomic (nuclear) and non-classical (membrane-associated) mechanisms, enabling rapid and sustained cellular responses.
• The pathway is essential for normal reproductive physiology, including endometrial receptivity, uterine quiescence, and mammary gland development.
• Dysregulation of progesterone receptor signaling is implicated in endometriosis, preterm birth, and hormone-dependent cancers such as breast cancer.
• Key genes in this pathway include PGR (PR-A and PR-B isoforms), coactivators such as NCOA1/2/3, corepressors such as NCOR1/2, and downstream targets like FKBP5 and GREB1.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are powerful tools to dissect causal roles of progesterone receptor signaling components in disease and development.
Description
The progesterone receptor signaling pathway (GO:0050847) is a nuclear receptor-mediated biological process that begins with progesterone binding to its intracellular receptor and culminates in the regulation of downstream cellular responses, most notably transcription. Progesterone, a steroid hormone, exerts pleiotropic effects on reproduction, development, and homeostasis by activating the progesterone receptor (PGR), a ligand-activated transcription factor. This pathway is fundamental to endometrial cycling, uterine function, and mammary gland biology, and its dysregulation contributes to a range of pathologies including endometriosis, preterm birth, and breast cancer. Understanding the molecular mechanisms of progesterone receptor signaling is therefore critical for both basic reproductive biology and therapeutic development. Researchers study this pathway using a variety of molecular, genomic, and imaging approaches, and CRISPR-based gene editing has emerged as a powerful tool to interrogate the function of pathway components in physiologically relevant models.
progesterone receptor signaling pathway At A Glance
| GO ID | GO:0050847 |
|---|---|
| GO term | progesterone receptor signaling pathway |
| Ontology | biological_process |
| Synonym | intracellular progesterone receptor signaling pathway; nuclear receptor-mediated progesterone signaling pathway; progesterone receptor signalling pathway |
| Major function | Mediates progesterone-dependent regulation of transcription and downstream cellular processes via the nuclear receptor PGR |
| Key receptor | Progesterone receptor (PGR), including isoforms PR-A and PR-B |
| Ligand | Progesterone (a steroid hormone) |
| Subcellular location | Predominantly nuclear, with membrane-associated non-classical signaling components |
| Major coactivators | NCOA1, NCOA2, NCOA3 (SRC family) |
| Major corepressors | NCOR1, NCOR2 (SMRT) |
What Is GO:0050847?
GO:0050847, progesterone receptor signaling pathway, is defined as a nuclear receptor-mediated signaling pathway initiated by progesterone binding to an intracellular receptor of the nuclear receptor protein family, and ending with regulation of a downstream cellular process, e.g. transcription. In simpler terms, it is the series of molecular events through which the steroid hormone progesterone binds to its receptor inside the cell and triggers changes in gene expression and other cellular activities.
Why Is progesterone receptor signaling pathway Important in Cell Biology?
Progesterone receptor signaling is central to female reproductive physiology and is a key driver in hormone-dependent diseases. It controls endometrial proliferation and differentiation, uterine quiescence during pregnancy, and mammary gland development. Aberrant signaling is linked to endometriosis, preterm birth, and breast cancer progression, making it a major therapeutic target. Understanding its mechanisms is essential for developing targeted interventions and for interpreting the effects of hormonal therapies.
• Regulates endometrial receptivity and menstrual cycle, critical for fertility and embryo implantation.
• Maintains uterine quiescence and prevents preterm birth; dysregulation is associated with preterm labor.
• Drives mammary gland development and is implicated in breast cancer pathogenesis.
• Plays a role in endometriosis pathogenesis through altered progesterone responsiveness.
• Mediates both genomic and rapid non-genomic effects, influencing diverse signaling cascades.
• Serves as a target for hormonal contraceptives and hormone replacement therapies.
• Interacts with other signaling pathways such as estrogen receptor and growth factor signaling.
• Provides a paradigm for understanding nuclear receptor biology and transcriptional regulation.
• Its components are potential biomarkers and therapeutic targets in reproductive cancers.
• CRISPR-based editing enables precise functional dissection of pathway genes in disease models.
What Happens During progesterone receptor signaling pathway?
Ligand Binding and Receptor Activation
In simple terms: Progesterone enters the cell and binds to its receptor, causing the receptor to change shape and become active.
Progesterone, a lipophilic steroid hormone, diffuses across the plasma membrane and binds to the ligand-binding domain of the progesterone receptor (PGR) in the cytoplasm or nucleus. This binding induces a conformational change, dissociates heat shock proteins (e.g., HSP90), and allows the receptor to dimerize. The activated receptor can then initiate both classical genomic and non-classical signaling events.
Genomic (Classical) Signaling: Transcriptional Regulation
In simple terms: The activated receptor moves into the nucleus and directly turns genes on or off.
Upon activation, PGR dimers translocate to the nucleus and bind to progesterone response elements (PREs) in the DNA, either as homodimers or heterodimers with other nuclear receptors. This binding recruits coactivator or corepressor complexes that modify chromatin and regulate RNA polymerase II activity, leading to changes in target gene transcription. Well-characterized target genes include FKBP5, GREB1, and SGK1.
Non-Classical (Non-Genomic) Signaling
In simple terms: The receptor can also act outside the nucleus to trigger rapid cellular responses.
In addition to nuclear actions, progesterone receptor signaling can occur through membrane-associated or cytoplasmic pools of PGR, or through other membrane receptors, leading to rapid activation of kinase cascades such as Src/Ras/MAPK and PI3K/Akt. These non-classical events can modulate cellular processes independent of transcription and often crosstalk with growth factor signaling pathways.
Coactivator and Corepressor Recruitment
In simple terms: Helper proteins are recruited to fine-tune whether genes are turned up or down.
The transcriptional outcome of PGR activation depends on the recruitment of coactivator complexes (e.g., NCOA1/2/3, which have histone acetyltransferase activity) or corepressor complexes (e.g., NCOR1/2, which recruit histone deacetylases). The balance between these complexes is influenced by cellular context, post-translational modifications, and ligand availability, thereby shaping tissue-specific responses.
Downstream Cellular Responses
In simple terms: The ultimate result is changes in cell behavior, such as growth, differentiation, or survival.
Activation of progesterone receptor signaling leads to diverse downstream effects, including regulation of cell proliferation, differentiation, apoptosis, and secretory activity. In the endometrium, it drives cyclical changes; in the mammary gland, it promotes lobuloalveolar development; and in cancer, it can promote tumorigenesis through interactions with the tumor microenvironment.
Key Genes Involved in GO:0050847 progesterone receptor signaling pathway
The following genes encode core components and modulators of the progesterone receptor signaling pathway, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PGR | Progesterone receptor; ligand-activated transcription factor; isoforms PR-A and PR-B | Central mediator of pathway; target for hormonal therapies; mutations linked to cancer |
| NCOA1 | Steroid receptor coactivator-1 (SRC-1); enhances PGR transcriptional activity | Modulates tissue-specific responses; implicated in breast cancer |
| NCOA2 | Steroid receptor coactivator-2 (SRC-2); coactivator for PGR | Affects PGR target gene expression; potential therapeutic target |
| NCOA3 | Steroid receptor coactivator-3 (SRC-3); coactivator for PGR | Overexpressed in breast cancer; influences PGR signaling |
| NCOR1 | Nuclear receptor corepressor-1; represses PGR-mediated transcription | Regulates gene repression; involved in endocrine resistance |
| NCOR2 | Nuclear receptor corepressor-2 (SMRT); represses PGR activity | Modulates PGR target genes; role in development |
| FKBP5 | FK506-binding protein 5; PGR target gene; feedback regulator | Biomarker of PGR activity; implicated in stress and cancer |
| GREB1 | Growth regulation by estrogen in breast cancer 1; PGR target gene | Marker of hormonal response; studied in breast cancer |
| SGK1 | Serum/glucocorticoid-regulated kinase 1; PGR target gene | Mediates ion transport and cell survival; downstream effector |
| ESR1 | Estrogen receptor alpha; crosstalks with PGR signaling | Key in endometrial and breast biology; interplay with PGR |
| AR | Androgen receptor; can modulate PGR signaling | Contributes to hormonal crosstalk in reproductive tissues |
| STAT3 | Signal transducer and activator of transcription 3; interacts with PGR | Mediates non-classical signaling; involved in cancer |
| SRC | Proto-oncogene tyrosine-protein kinase Src; mediates rapid non-genomic signaling | Phosphorylates PGR; affects cell motility |
| MAPK1 | Mitogen-activated protein kinase 1 (ERK2); downstream of non-classical signaling | Regulates proliferation and differentiation |
| AKT1 | AKT serine/threonine kinase 1; survival signaling | Crosstalk with PGR; promotes cell survival |
| CDK2 | Cyclin-dependent kinase 2; cell cycle regulator | Modulated by PGR signaling; affects proliferation |
| CCND1 | Cyclin D1; cell cycle progression | PGR-regulated; drives proliferation in breast and endometrium |
| VEGFA | Vascular endothelial growth factor A; angiogenesis | Induced by PGR in endometrium; supports vascular remodeling |
How Is progesterone receptor signaling pathway Regulated?
Progesterone receptor signaling is tightly regulated at multiple levels. Ligand availability is controlled by steroidogenic enzymes and circulating hormone levels. Receptor activity is modulated by post-translational modifications, including phosphorylation by kinases such as CDK2 and Src, which can alter transcriptional activity and stability. Coactivator and corepressor recruitment provides an additional layer of regulation, influenced by cellular context and signaling crosstalk. Non-classical pathways involving MAPK and PI3K/Akt can feed back to modulate PGR function. Additionally, PGR expression itself is regulated by estrogen and other factors, creating complex feedback loops.
progesterone receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PGR | Endometriosis, preterm birth, breast cancer | PGR knockout or point-mutant cell lines; patient-derived organoids |
| NCOA1/2/3 | Breast cancer, endocrine resistance | Coactivator knockout or overexpression in breast cancer cells |
| NCOR1/2 | Endometrial cancer, hormone resistance | Corepressor knockout in endometrial cells |
| FKBP5 | Stress-related disorders, cancer | FKBP5 reporter assays; CRISPR knockout in cancer cell lines |
| ESR1 | Endometrial and breast cancer | ESR1 mutant knock-in models; crosstalk studies with PGR |
Endometriosis
Endometriosis is a chronic inflammatory condition characterized by ectopic endometrial-like tissue. Altered progesterone receptor signaling, particularly reduced PGR-B expression and progesterone resistance, contributes to the pathogenesis of endometriosis. This resistance impairs the ability of progesterone to suppress inflammation and promote differentiation, leading to lesion survival and pain.
Preterm Birth
Progesterone receptor signaling is essential for maintaining uterine quiescence during pregnancy. Dysregulation of PGR isoforms or cofactors can lead to premature activation of uterine contractility, resulting in preterm birth. Studies have shown that changes in the PGR-A/PGR-B ratio and altered coactivator recruitment are associated with preterm labor.
Breast Cancer
In hormone-dependent breast cancers, progesterone receptor signaling promotes tumorigenesis through both genomic and non-genomic mechanisms. PGR activation can stimulate proliferation and interact with the tumor microenvironment, including cancer-associated fibroblasts, to enhance tumor growth. Targeting PGR signaling is a key therapeutic strategy in ER+ breast cancer.
Endometrial Cancer
Progesterone receptor signaling plays a protective role in the endometrium by opposing estrogen-driven proliferation. Loss of PGR expression or function is associated with endometrial hyperplasia and cancer progression. Progestin therapy is used in clinical management, highlighting the importance of intact PGR signaling.
From progesterone receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PGR isoform-specific knockout alter transcriptional response? | CRISPR knockout of PGR-A or PGR-B in endometrial or breast cancer cell lines |
| What is the effect of a specific PGR point mutation on ligand binding? | CRISPR point mutation knock-in of PGR ligand-binding domain |
| How does a disease-associated PGR variant affect signaling? | Knock-in of mutant PGR in isogenic cell lines |
| Where is PGR localized and how does it traffic? | Tagged knock-in of PGR with fluorescent protein for live imaging |
| What is the effect of PGR overexpression on tumor growth? | Overexpression of PGR in breast cancer cell lines or xenografts |
| Which coactivators are essential for PGR target gene activation? | CRISPR knockout of NCOA1/2/3 in PGR-positive cells |
How to Study the progesterone receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify PGR target genes and pathways |
| ChIP-seq | Genome-wide PGR binding sites | Map progesterone response elements and cofactor recruitment |
| Proteomics | Protein interactions and modifications | Discover PGR interactome and signaling crosstalk |
| Live-cell imaging | Receptor localization and dynamics | Study PGR trafficking and cofactor interactions |
| Reporter assays | Transcriptional activity of PGR | Screen for modulators of PGR signaling |
| CRISPR screening | Functional gene dependencies | Identify synthetic lethal partners with PGR |
| Western blot | Protein expression and phosphorylation | Validate PGR isoform levels and activation |
| qRT-PCR | Quantitative mRNA levels | Measure PGR target gene expression |
Transcriptomic Profiling (RNA-seq)
RNA sequencing is widely used to identify global changes in gene expression upon progesterone stimulation or PGR knockout. This method reveals PGR target genes and pathways, such as FKBP5 and GREB1, and can uncover tissue-specific responses.
Chromatin Immunoprecipitation (ChIP-seq)
ChIP-seq for PGR identifies genome-wide binding sites and helps define direct transcriptional targets. It is used to map progesterone response elements and assess cofactor recruitment.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can quantify PGR-interacting proteins and post-translational modifications, providing insights into non-classical signaling and crosstalk.
Live-Cell Imaging
Fluorescently tagged PGR (e.g., GFP-PGR) enables real-time visualization of receptor dynamics, nuclear translocation, and interactions with cofactors in living cells.
How CRISPR Can Be Used to Study GO:0050847 progesterone receptor signaling pathway
Knockout
CRISPR knockout of PGR or its cofactors in cell lines (e.g., T47D, MCF-7, Ishikawa) allows researchers to determine the requirement for specific components in progesterone-responsive gene expression and cellular phenotypes. Knockout models can also be used to study endocrine resistance.
Point Mutation
Introducing precise point mutations in PGR (e.g., in the ligand-binding domain or DNA-binding domain) via CRISPR base editing or homology-directed repair helps dissect the functional impact of clinically relevant variants and post-translational modification sites.
Knock-in
Knock-in of tagged PGR (e.g., GFP or HA) enables live-cell imaging and chromatin immunoprecipitation without overexpression artifacts. Knock-in of disease-associated mutations in isogenic backgrounds provides causal insights.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of PGR or its coactivators can model hormone-dependent tumor growth and identify downstream effectors. Overexpression models are useful for studying gain-of-function mechanisms in cancer.
How EDITGENE Supports progesterone receptor signaling pathway Research
Researchers studying progesterone receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in hormone response, disease progression, or therapeutic resistance. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes in the progesterone receptor signaling pathway.
Contact EDITGENE today to design your custom CRISPR model for progesterone receptor signaling pathway research.
Frequently Asked Questions About progesterone receptor signaling pathway
What is the progesterone receptor signaling pathway?
It is the biological process (GO:0050847) initiated by progesterone binding to its intracellular receptor, leading to regulation of downstream cellular processes such as transcription.
What genes are involved in progesterone receptor signaling?
Key genes include PGR (progesterone receptor), coactivators NCOA1/2/3, corepressors NCOR1/2, and target genes like FKBP5 and GREB1.
How does progesterone receptor signaling work?
Progesterone binds to PGR, causing receptor activation, dimerization, and binding to DNA to regulate transcription; it also triggers rapid non-genomic signaling.
What diseases are associated with progesterone receptor signaling?
Dysregulation is linked to endometriosis, preterm birth, breast cancer, and endometrial cancer.
What are the two isoforms of progesterone receptor?
PGR exists as two major isoforms, PR-A and PR-B, which arise from alternative promoters and have distinct transcriptional activities.
How can CRISPR be used to study progesterone receptor signaling?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of PGR and its partners in disease-relevant cell lines.
What is non-classical progesterone receptor signaling?
It refers to rapid, membrane-associated signaling events triggered by progesterone that do not directly involve nuclear transcription, often activating kinase cascades.
Which coactivators are important for progesterone receptor signaling?
The SRC family coactivators NCOA1, NCOA2, and NCOA3 are critical for enhancing PGR-mediated transcription.
How is progesterone receptor signaling regulated?
It is regulated by ligand availability, post-translational modifications, cofactor recruitment, and crosstalk with other signaling pathways.
What methods are used to study progesterone receptor signaling?
Common methods include RNA-seq, ChIP-seq, proteomics, live-cell imaging, reporter assays, and CRISPR screening.
Conclusion
The progesterone receptor signaling pathway (GO:0050847) is a fundamental nuclear receptor-mediated process that governs reproductive physiology and contributes to major diseases such as endometriosis, preterm birth, and breast cancer. Its complexity, involving classical genomic and non-classical signaling, offers numerous targets for therapeutic intervention. Advances in CRISPR-based gene editing and functional genomics are enabling precise dissection of pathway components, promising to accelerate the development of novel diagnostics and treatments.
References
- 1. Grimm SL et al.. 2016. Progesterone Receptor Signaling Mechanisms.. J Mol Biol 428(19):3831-49 PMID: 27380738
- 2. Dias Da Silva I et al.. 2024. Unraveling the Dynamics of Estrogen and Progesterone Signaling in the Endometrium: An Overview.. Cells 13(15) PMID: 39120268
- 3. Wang Y et al.. 2020. The Origin and Pathogenesis of Endometriosis.. Annu Rev Pathol 15:71-95 PMID: 31479615
- 4. Garg D et al.. 2017. Progesterone-Mediated Non-Classical Signaling.. Trends Endocrinol Metab 28(9):656-668 PMID: 28651856
- 5. Aarts MT et al.. 2023. A molecular toolbox to study progesterone receptor signaling.. J Mammary Gland Biol Neoplasia 28(1):24 PMID: 38019315
- 6. Boonyaratanakornkit V et al.. 2021. Progesterone Receptor Signaling in the Breast Tumor Microenvironment.. Adv Exp Med Biol 1329:443-474 PMID: 34664251
- 7. Wu SP et al.. 2017. Progesterone Receptor Signaling in Uterine Myometrial Physiology and Preterm Birth.. Curr Top Dev Biol 125:171-190 PMID: 28527571
- 8. Diep CH et al.. 2024. Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer.. Endocrinology 165(9) PMID: 39041201
